InvestorsHub Logo
Followers 1264
Posts 10395
Boards Moderated 1
Alias Born 11/19/2013

Re: None

Tuesday, 05/23/2017 12:04:44 PM

Tuesday, May 23, 2017 12:04:44 PM

Post# of 39284
**Why the Stock UCPA can see .05-.10 Penny Potential and is extremely Undervalued and still Unnoticed.**

1. Revenue:

14,098,000 revenue Q1 2017 while being a .0045 priced stock? This has higher revenue then many OTC companies that are already past .10 cents. 50,658,000 in revenue in year of 2016. 50 million in revenue, that is outstanding for an OTC company.

2010: 8.6 million in revenue
2011: 15.5 million in revenue
2012: 18.3 million in revenue
2013: 20.4 million in revenue
2014: 48.1 million in revenue
2015: 39.1 million in revenue
2016: 50.6 million in revenue
2017 Q1 : 14 million in revenue on pace to beat 50.6 for the year

Current Market Value of Company is 7,280,493 at a .0045 share price = extremely undervalued when they are bringing in 50.6 million revenue a year.

2. Umbrella company contracts and partnerships with dozens of big companies such as 7/11, western union, Pfizer, and Weber. Plus many more below : (Pictures)

3. Share Structure:
Main question being asked is well how about the 2 billion AS and 1.6 billion OS?

Easy Answer to this: Beneficial owners have steadily increased their stake in their company. They own approximately 70% of the share count which is seen below. The company's number of outstanding shares is unchanged since early 2012. UCPA has no debt and no dilution, which is very rare in the OTC.

-AS ALWAYS ALL IN MY OPINION.

Millionaire at 21.I consider myself one of the best technical traders and I would challenge anyone to that. I run a very successful day-trading team and have been an apprentice under some of the greatest day-traders and financial wizards from Wall Street.